Target intelligence / Profile preview

Protein EURL homolog (C21orf91)

Target
C21orf91
Molecular classification
Other (structural protein, modulator of signaling, not a receptor, enzyme, transporter, or classical transcription factor)
01

Overview

Protein EURL homolog (C21orf91) is a multifunctional gene product with pivotal roles in neural progenitor proliferation, neuronal differentiation, and dendritic spine formation in the developing cerebral cortex, with relevance to neurodevelopmental disorders such as Down Syndrome. It acts as a molecular hub, influencing cellular fate (e.g., differentiation of oligodendroglial cells and glial population balance), modulating inflammatory signaling pathways (notably affecting NF-κB activity in hepatocellular carcinoma), affecting susceptibility to viral infections (herpes simplex labialis), and contributing to tumor phenotype regulation in melanocytic neoplasms. C21orf91 is not classified as a receptor, enzyme, or common drug target; instead, it is an emerging molecular modulator with broad impact on disease pathogenesis and cellular development.

Other names
C21orf91EURLC21orf14C21orf38YG81CSSG1cold sore susceptibility gene 1early undifferentiated retina and lens
02

Biological functions

Neural development, especially cortical neuron differentiationDendritic spine developmentOligodendroglial precursor cell maturation and myelinationModulation of inflammatory signaling (including effects on NF-κB activity)Cutaneous viral susceptibility, specifically herpes simplex labialis (cold sores)Cell phenotype regulation in melanoma (switch between migratory and proliferative states)
03

Disease associations

Down syndrome (altered dosage leads to neural deficits)Hepatocellular carcinoma (inflammatory, metastatic behavior)Melanocytic neoplasia and melanomaCold sore susceptibility (herpes simplex virus)Intellectual disability related to DSBlood pressure regulation (suggested by association studies)

Beyond the preview

Go deeper on Protein EURL homolog (C21orf91).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein EURL homolog (C21orf91).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call